Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Chief Medical Officer acquired 829 shares (grant or award)
  7. 4 Grant or award Executive VP, Research acquired 96 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 931 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion Chief Operating Officer acquired 50,440 shares (option exercise)
  12. 4 Exercise or conversion Chief Medical Officer acquired 28,372 shares (option exercise)
  13. 4 Other disposition Director disposed of 3,000 shares (other)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Financial Officer acquired 1,554 shares (grant or award)
  16. 4/A Exercise or conversion Vice President of Discovery acquired 3,152 shares (option exercise)
  17. 4 Exercise or conversion Vice President of Discovery acquired 3,152 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 211 filings